Adagene Inc. (Nasdaq: ADAG) announced that China's National Medical Products Administration (NMPA) has cleared an investigational new drug (IND) application ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE